Nancy Lin

Default Biography Avatar

Nancy Uan-Tsin Lin, MD, is a medical oncologist at Dana-Farber Cancer Institute (DFCI) and assistant professor of medicine at Harvard Medical School. Dr Lin received her medical degree at Harvard Medical School and subsequently completed her residency in internal medicine at Brigham & Women’s Hospital and a fellowship in hematology/oncology at Dana-Farber/Partners Cancer Care. In 2005, she joined the staff of the Breast Oncology Center at DFCI. Dr Lin's focus is on developing novel targeted therapies for patients with advanced breast cancer. A particular area of interest is in expanding the treatment options for patients with brain metastases, which have become an increasing clinical problem in recent years. Dr Lin is also leading the Catalyst for the Cure study, which enrolls women with advanced breast cancer and with goals of collecting tissue and blood samples for translational research, describing clinical outcomes, studying quality of life, and improving access to clinical trials. Dr Lin's honors and awards include a Young Investigator Award and Career Development Award from the American Society of Clinical Oncology. She is a member of the Massachusetts Medical Society, American Society of Clinical Oncology, Cancer and Leukemia Group B, and Translational Breast Cancer Research Consortium. She is co-chair of the Breast International Group-North American Breast Group metastatic working group. Dr Lin serves as ad hoc reviewer for numerous publications, including the Journal of Clinical Oncology, Breast Cancer Research and Treatment, and Clinical Cancer Research.